Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rash

• Nicholas A. Trum, BS,
• Jasmine Zain, MD,
• Chelsea Abad, NP,
• Steven T. Rosen, MD,
• Christiane Querfeld, MD, PhD

Affiliations

Nicholas A. Trum, BS

Division of Dermatology, Beckman Research Institute, City of Hope Medical Center, Duarte, California; Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel

Jasmine Zain, MD

Department of Hematology and Hematopoietic Cell Transplantation, Beckman Research Institute, City of Hope Medical Center, Duarte, California

Chelsea Abad, NP

Division of Dermatology, Beckman Research Institute, City of Hope Medical Center, Duarte, California

Steven T. Rosen, MD

Department of Hematology and Hematopoietic Cell Transplantation, Beckman Research Institute, City of Hope Medical Center, Duarte, California; Beckman Research Institute, City of Hope Medical Center, Duarte, California

Christiane Querfeld, MD, PhD

Division of Dermatology, Beckman Research Institute, City of Hope Medical Center, Duarte, California; Department of Pathology, Beckman Research Institute, City of Hope Medical Center, Duarte, California; Beckman Research Institute, City of Hope Medical Center, Duarte, California; Correspondence to: Christiane Querfeld, MD, PhD, City of Hope and Beckman Research Institute, 1500 E. Duarte Road, Duarte, CA 91010.